Back
ESC2025 Premium Access

Prevention of aortic valve stenosis through modulation of LXRb using saringosterol

Session: Molecular mechanisms and therapeutic targets in aortic valve disease and calcification
Topic: Valvular Heart Disease
Speaker: Doctor M. Noethel (Bonn, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Moritz Noethel

Heartcenter Bonn, University Hospital Bonn, Bonn (Germany)
0 follower

7 more presentations in this session

The K+ channel KCa3.1 promotes contraction in aortic stenosis valve myofibroblast cells

Speaker: Miss M. Whitfield (Leicester, GB)

Access
Abstract
Slides
Like
Thumbnail

Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound.

Speaker: Ms M. El Ouraoui (Leiden, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

The role of transcription factor junb in aortic valvular interstitial cell calcification

Speaker: Doctor C. Song (Chengdu, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Glycolysis blockade reduces synthesis and maturation of glycoproteins as well as leukocyte adhesion in inflamed aortic valve cells

Speaker: Miss M. Peral-Rodrigo (Valladolid, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Activation of cGMP-PKG signaling pathway attenuates aortic valve calcification through ULK1-mediated autophagy

Speaker: Doctor Y. Wang (Chengdu, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Molecular mechanisms and therapeutic targets in aortic valve disease and calcification

Speakers: Doctor M. Noethel, Miss M. Whitfield, Ms M. El Ouraoui, Doctor C. Song, Miss M. Peral-Rodrigo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources